Please login to the form below

Not currently logged in
Email:
Password:

MRSA

This page shows the latest MRSA news and features for those working in and with pharma, biotech and healthcare.

Basilea moves closer to US filing of novel antibiotic

Basilea moves closer to US filing of novel antibiotic

MRSA). Results from that trial are due in 2021 and if positive will clear the way for an FDA filing. ... the high incidence of MRSA in US hospitals and the higher propensity in the US to use novel products”.

Latest news

  • Motif Bio preps US filing after antibiotic clears phase III Motif Bio preps US filing after antibiotic clears phase III

    resistance to other antibiotics, including ‘superbugs’ such as methicillin resistant Staphylococcus aureus (MRSA).

  • CHMP backs AZ's 'superbug' antibiotic product CHMP backs AZ's 'superbug' antibiotic product

    In 2011 AZ launched novel cephalosporin Zinforo (ceftaroline fosamil), the first drug in the class to be approved with data showing it could tackle the superbug methicillin-resistant Staphylococcus aureus (MRSA).

  • Pfizer takes MRSA vaccine into phase IIb trial Pfizer takes MRSA vaccine into phase IIb trial

    Trial will involve patients undergoing elective spinal fusion surgery.  . Pfizer has started enrolling patients into a mid-stage trial of its candidate vaccine for 'superbug' methicillin-resistant Staphylococcus aureus (MRSA). ... The company is trying

  • Basilea’s novel antibiotic reaches UK market Basilea’s novel antibiotic reaches UK market

    It is a broad-spectrum antibiotic and can be used to treat infections caused both Gram- positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas species. ... Treatment failure rates in pneumonia,

  • Cubist gets green light from FDA for new antibiotic Sivextro Cubist gets green light from FDA for new antibiotic Sivextro

    Sivextro is in the oxazolidinone class of antibiotics has been approved to treat ABSSSIs caused by certain Gram-positive bacteria, including 'superbug' methicillin-resistant Staphylococcus aureus (MRSA), and is available in ... Until the approval of

More from news
Approximately 4 fully matching, plus 77 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics